摘要
经前烦躁障碍症(premenstrual dysphoric disorder,PMDD)好发于适龄期妇女,因其发病机制尚不明确,而造成PMDD临床治疗药物的疗效欠佳且副作用严重。该文综述了中医和现代医学研究中有关PMDD的发病机制和治疗药物的研究进展,旨在更好地促进PMDD的相关治疗与相关新药研发。
Premenstrual dysphoria(PMDD) often occurs in women of appropriate age. The pathogenesis of PMDD is not clear,which results in poor efficacy and serious side effects of clinical drugs. In this paper,the pathogenesis and therapeutic drugs of PMDD in traditional Chinese medicine and modern medicine are reviewed,in order to better promote the treatment of PMDD and related new drug research and development.
作者
夏小雯
宋春红
乔明琦
张长龙
王香君
马明钰
XIA Xiao-wen;SONG Chun-hong;QIAO Ming-qi;ZHANG Chang-long;WANG Xiang-jun;MA Ming-yu(Emotional Disease Innovation Team of Shandong University of Traditional Chinese Medicine,Jinan,150355,China)
出处
《神经药理学报》
2019年第6期36-40,共5页
Acta Neuropharmacologica
基金
国家科学技术部科技重大新药创制专项(No.2017ZX09301064)
柴芍皂苷软胶囊有效成分脑影像示踪技术及其药理机制研究。
